IQVIA · 1 day ago
Sr. CRA, Sponsor Aligned, Oncology
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. The Clinical Research Associate will monitor and manage clinical trial sites, ensuring compliance with study protocols and regulations while contributing to groundbreaking cancer research.
AnalyticsHealth CareLife Science
Responsibilities
Conduct selection, initiation, monitoring, and close-out visits in line with GCP and ICH guidelines
Collaborate with sites to develop and track recruitment plans, ensuring project needs are met
Provide protocol and study training to sites, maintaining regular communication to manage expectations and address issues
Assess site practices for protocol adherence and regulatory compliance, escalating quality issues as needed
Oversee regulatory submissions, recruitment, enrollment, CRF completion, and data query resolution
Ensure all site documents are filed in the Trial Master File (TMF) and Investigator’s Site File (ISF) per GCP/ICH and local regulations
Generate visit reports, follow-up letters, and other necessary documentation
Mentor clinical staff through co-monitoring and training visits
Work closely with study team members to support project execution
Qualification
Required
BS degree
Phase 1 oncology experience
Proficient in GCP and ICH guidelines
Strong therapeutic and protocol knowledge in Phase 1 oncology trials
Excellent computer skills, including Microsoft Office and mobile devices
Effective communication, organizational, and problem-solving abilities
Strong time management skills
Ability to build and maintain effective working relationships
Preferred
A degree in a scientific discipline or healthcare
3+ years of on site oncology monitoring experience
1.5+ years of oncology monitoring experience can be considered
Benefits
Incentive plans
Bonuses
Health and welfare and/or other benefits
Company
IQVIA
IQVIA provides analytics, compliance, and management solutions to the life sciences industry.
Funding
Current Stage
Public CompanyTotal Funding
$3.5B2025-06-02Post Ipo Debt· $2B
2023-11-14Post Ipo Debt· $500M
2023-05-18Post Ipo Debt· $1B
Leadership Team
Recent News
Sabin Vaccine Institute
2025-12-04
Company data provided by crunchbase